MedTrace Logo

Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World Study

NCT06481449 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2600

Last updated 2024-07-01

No results posted yet for this study

Summary

Cervical and upper thoracic esophageal cancer (ESCA) presents treatment challenges due to limited clinical evidence. This multi-center study (ChC\&UES) explores radical radio(chemo)therapy efficacy and safety

Conditions

  • Esophageal Neoplasm

Sponsors & Collaborators

  • Tianjin Medical University Cancer Institute and Hospital

    collaborator OTHER

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    collaborator OTHER

  • Fujian Cancer Hospital

    collaborator OTHER_GOV

  • Fudan University

    collaborator OTHER

  • Shandong Cancer Hospital and Institute

    collaborator OTHER

  • Hebei Medical University Fourth Hospital

    lead OTHER

Principal Investigators

  • Wenbin Shen · Hebei Medical University Fourth Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2024-10-01
Completion
2024-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06481449 on ClinicalTrials.gov